Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized controlled open-label trial of enoxaparin thromboprophylaxis in non-surgical cancer patients receiving systemic antineoplastic therapy
2007-002036-28Phase 2Terminated
- Sponsor
- Universitätsmedizin Essen
- Start
- Feb 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of enoxaparin in venous thromboembolism (VTE), thrombosis and pulmonary embolism (PE) (2 arms), sponsored by Universitätsmedizin Essen. Primary endpoint: Incidence of thrombosis and/or pulmonary embolism. Started Feb 2009; status: terminated.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)thrombosispulmonary embolism (PE)
Beyond the preview
Go deeper on 2007-002036-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002036-28.